Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Clarithromycin is a semisynthetic macrolide antibiotic derived from erythromycin, characterized by the addition of a methyl group at the C-6 hydroxyl position, which enhances its acid stability and clinical efficacy. This modification allows clarithromycin to be effective against a broad spectrum of bacterial infections, including respiratory tract infections, skin infections, and Helicobacter pylori infection. Structurally, clarithromycin belongs to the 14-membered macrolide class, and its derivatives have been synthesized to improve antibacterial activity against resistant strains. The gene information related to clarithromycin involves its biosynthesis and the genetic encoding of biosensors that report its activity, highlighting its role in combating bacterial resistance. Clarithromycin's functionality is primarily attributed to its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the growth and proliferation of bacteria.
仅用于科研。不用于诊断过程。未经明确授权不得转售。